Heres a simplified breakdown: GLP-1 Agonism: This action helps increase insulin secretion when blood sugar is high, suppresses glucagon (a hormone that raises blood sugar), slows down gastric emptying (which helps with satiety), and acts on the brain to reduce appetite
Oral GLP-1 Medications: Orforglipron and Beyond The next frontier is oral GLP-1 medications like Orforglipron, developed by Eli Lilly
The intensity and prevalence differ per person
Also, a phase 3b trial was conducted to investigate the efficacy and safety of semaglutide as add-on to therapy with sodium glucose cotransporter 2 (SGLT2) inhibitor
Data availability Proteomic results and summary association data are available through a dashboard at Individual participant data from the STEP 1 and STEP 2 clinical trials can be shared in datasets in a de-identified and anonymized format
Combinations of immunogenic vaccines, for instance, in heterologous prime-boost regimens, multiplexed vaccines, or serial vaccination, may be the key to achieving robust and durable immunity
